BeStock  
Stocks › Biotechnology › ORIC

Oric Pharmaceuticals ORIC

US equityMarket cap rank #3332Biotechnology
$7.36 −$0.34 (-4.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.37 +0.14%
Open$7.58
Prev close$7.70
Day range$7.28 – $8.00
Volume1.46M
Market cap$764.94M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership120.8%-1.90 pts vs. prior quarter
Institutions holding222+12 vs. prior quarter
Insider trades (recent)23 buys / 27 sellsNet selling
Short interest10.35% of floatDays to cover 4.8 · as of 30 Oct 2026
Short-sale volume share26.4%5-day average of daily volume

Short-sale volume as % of daily volume

9%21%33%44%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$450.4K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$104.3KSuper+$346.0KBig−$871.3KMid−$1.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 31.5% of shares outstanding.

Largest holders

  • Nextech Invest Ltd.6.91%
  • BlackRock6.73%
  • EcoR1 Capital, LLC6.49%
  • T. Rowe Price Group, Inc.6.38%
  • Viking Global Investors LP4.95%
  • SR One Capital Management, LP4.45%
  • VR Management, LLC4.17%
  • State Street Global Advisors3.98%

By investor type

  • Mutual Fund43.28%
  • Hedge Fund38.04%
  • VC/PE Fund31.87%
  • Public Company5.18%
  • Individual/Insider1.04%
  • Private Company1.01%
  • Family Office/Trust0.99%
  • Government Pension Fund0.18%

Reported short interest has fallen from 17.74% to 10.35% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Artal Group S.A. VC/PE Fund 2026/Q3 +360,000 2.3%
Zweig-DiMenna Associates, Inc. Hedge Fund 2026/Q3 +268,790 0.3%
Morgan Stanley Public Company 2026/Q3 +242,242 2.0%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +242,242 2.0%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +1,535,826 1.5%
AIHC Capital Management Limited Hedge Fund 2026/Q3 +1,368,909 3.7%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,229,771 6.4%
State Street Global Advisors Mutual Fund 2026/Q3 +1,191,804 4.7%
Algert Global LLC Hedge Fund 2026/Q3 +1,078,943 1.2%
BlackRock Mutual Fund 2026/Q3 +839,421 6.6%
Jones Hill Capital LP Hedge Fund 2026/Q3 +747,313 0.7%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +707,588 1.0%
Millennium Management LLC Hedge Fund 2026/Q3 +663,682 0.7%
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +605,683 1.1%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +603,664 0.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
19 Oct 2026 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -14,000 $13.53 69,828
30 Sep 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -3,200 $12.91 241,772
30 Sep 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Derivative Exercise and Sale -3,500 $12.91 241,772
27 Sep 2026 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -13,400 $13.53 69,828
23 Sep 2026 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -600 $13.51 69,828
25 Aug 2026 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -77,000 $13.69 69,828
23 Jul 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Open Market Disposition -9,600 $12.02 244,972
23 Jul 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Derivative Exercise and Sale -3,500 $12.02 244,972
5 Jul 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -300 $12.00 254,572
23 Feb 2026 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -52,000 $13.51 68,148
15 Jan 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -6,700 $12.00 254,872
1 Jan 2026 Pratik Multani Chief Medical Officer Other Derivative Acquisition +35,500 – 35,500
1 Jan 2026 Pratik Multani Chief Medical Officer Other Derivative Acquisition +214,000 $8.17 214,000
1 Jan 2026 Angie You Independent Director Other Derivative Acquisition +40,000 $8.17 40,000
1 Jan 2026 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Other Derivative Acquisition +40,000 $8.17 40,000
1 Jan 2026 Lori Kunkel Independent Director Other Derivative Acquisition +40,000 $8.17 40,000
1 Jan 2026 Mardi Dier Independent Director Other Derivative Acquisition +40,000 $8.17 40,000
1 Jan 2026 Jacob Chacko Chief Executive Officer Other Derivative Acquisition +112,500 – 112,500
1 Jan 2026 Jacob Chacko Chief Executive Officer Other Derivative Acquisition +675,000 $8.17 675,000
1 Jan 2026 Steven Hoerter Independent Director Other Derivative Acquisition +40,000 $8.17 40,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,730,120 10.4% 4.8
15 Oct 2026 15,422,384 14.9% 10.5
30 Sep 2026 16,315,970 15.7% 9.9
15 Sep 2026 17,532,473 16.9% 14.2
31 Aug 2026 17,266,340 16.7% 16.2
14 Aug 2026 18,392,742 17.7% 11.0

Discussion

No comments yet — be the first to weigh in on ORIC.

Sign in to join the discussion.

Scroll to Top